| scholarly article | Q13442814 |
| P2093 | author name string | Yasuyoshi Ouchi | |
| Hiroshi Yamamoto | |||
| Takahide Nagase | |||
| Hiroo Wada | |||
| Eijiro Ohga | |||
| Tetsuji Tomita | |||
| P2860 | cites work | Adhesion receptors of the immune system | Q29616393 |
| Intercellular adhesion molecule 1 (ICAM-1) has a central role in cell-cell contact-mediated immune mechanisms | Q33570702 | ||
| Recognition of an endothelial determinant for CD 18-dependent human neutrophil adherence and transendothelial migration | Q35593510 | ||
| A leukocyte homologue of the IL-8 receptor CXCR-2 mediates the accumulation of macrophages in atherosclerotic lesions of LDL receptor-deficient mice | Q37377448 | ||
| Cooperation between transcription factor AP-1 and NF-kappaB in the induction of interleukin-8 in human pancreatic adenocarcinoma cells by hypoxia | Q38316479 | ||
| Plasma concentration of soluble intercellular adhesion molecule 1 and risks of future myocardial infarction in apparently healthy men. | Q40872170 | ||
| Association of sleep apnoea with myocardial infarction in men. | Q41174703 | ||
| Effects of budesonide and formoterol on NF-kappaB, adhesion molecules, and cytokines in asthma | Q43757284 | ||
| Intercellular adhesion molecule-1 (ICAM-1) in the pathogenesis of asthma | Q44385702 | ||
| Insulin resistance and sleep-disordered breathing in healthy humans | Q46141762 | ||
| Decreased lesion formation in CCR2-/- mice reveals a role for chemokines in the initiation of atherosclerosis | Q46897070 | ||
| The efficacy of nasal continuous positive airway pressure in the treatment of obstructive sleep apnea syndrome is proven | Q48720134 | ||
| Increased levels of circulating ICAM-1, VCAM-1, and L-selectin in obstructive sleep apnea syndrome | Q48753031 | ||
| Comparison of therapeutic and subtherapeutic nasal continuous positive airway pressure for obstructive sleep apnoea: a randomised prospective parallel trial | Q48759031 | ||
| 24-hour ambulatory blood pressure variability in obstructive sleep apnea syndrome | Q48870354 | ||
| Adiposity and cardiovascular risk factors in men with obstructive sleep apnea | Q48870363 | ||
| Long-term outcome for obstructive sleep apnea syndrome patients. Mortality | Q48951244 | ||
| Mortality and apnea index in obstructive sleep apnea. Experience in 385 male patients | Q48956111 | ||
| New indices of ischemic heart disease and aging: studies on the serum levels of soluble intercellular adhesion molecule-1 (ICAM-1) and soluble vascular cell adhesion molecule-1 (VCAM-1) in patients with hypercholesterolemia and ischemic heart diseas | Q50952139 | ||
| MCP-1 and IL-8 trigger firm adhesion of monocytes to vascular endothelium under flow conditions | Q59064735 | ||
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | obstructive sleep apnea | Q16606552 |
| P304 | page(s) | 179-184 | |
| P577 | publication date | 2002-09-27 | |
| P1433 | published in | Journal of Applied Physiology | Q1091719 |
| P1476 | title | Effects of obstructive sleep apnea on circulating ICAM-1, IL-8, and MCP-1. | |
| P478 | volume | 94 |
| Q33747170 | Abnormal cytokine profile in patients with obstructive sleep apnea-hypopnea syndrome and erectile dysfunction |
| Q48436771 | Absence of blood pressure, metabolic, and inflammatory marker changes after adenotonsillectomy for sleep apnea in Greek children |
| Q34996041 | Adhesion molecule increases in sleep apnea: beneficial effect of positive airway pressure and moderation by obesity. |
| Q34466982 | Advances in sleep-disordered breathing. |
| Q48243240 | Analysis of genetic expression in the soft palate of patients with obstructive sleep apnea |
| Q47655185 | Analysis of systemic and airway inflammation in obstructive sleep apnea |
| Q37161830 | Atherosclerosis and arterial stiffness in obstructive sleep apnea--a cardiovascular magnetic resonance study |
| Q28082137 | Biomarkers associated with obstructive sleep apnea: A scoping review |
| Q34697950 | Biomarkers to improve diagnosis and monitoring of obstructive sleep apnea syndrome: current status and future perspectives |
| Q36800544 | Brain structural changes in obstructive sleep apnea |
| Q48275734 | Cardiovascular consequences of sleep apnea |
| Q36883231 | Cardiovascular outcomes of CPAP therapy in obstructive sleep apnea syndrome |
| Q61454635 | Cardiovascular outcomes of continuous positive airway pressure therapy for obstructive sleep apnea |
| Q36225753 | Cardiovascular risk markers in obstructive sleep apnoea syndrome and correlation with obesity |
| Q41081810 | Chronic intermittent hypoxia induces local inflammation of the rat carotid body via functional upregulation of proinflammatory cytokine pathways |
| Q48483501 | Circulating ICAM-1 and VCAM-1 levels in patients with obstructive sleep apnea syndrome. |
| Q38101728 | Circulating adhesion molecules in obstructive sleep apnea and cardiovascular disease |
| Q37397088 | Cystatin C Levels in Middle-Aged Patients with Obstructive Sleep Apnea Syndrome. |
| Q48381570 | Cytokine production from peripheral blood mononuclear cells and polymorphonuclear leukocytes in patients studied for suspected obstructive sleep apnea |
| Q48424249 | Day-night variations of serum interleukin-6 in patients with severe obstructive sleep apnea syndrome before and after continuous positive airway pressure (CPAP). |
| Q34079885 | Deletion of metallothionein exacerbates intermittent hypoxia-induced oxidative and inflammatory injury in aorta |
| Q34697479 | Diagnostic capability of biological markers in assessment of obstructive sleep apnea: a systematic review and meta-analysis. |
| Q35142653 | Dichotomous effects of chronic intermittent hypoxia on focal cerebral ischemic injury |
| Q48016701 | Effect of chronic continual- and intermittent hypoxia-induced systemic inflammation on the cardiovascular system in rats |
| Q35832496 | Effects of adenotonsillectomy on plasma inflammatory biomarkers in obese children with obstructive sleep apnea: A community-based study. |
| Q36947591 | Elevation of plasma basic fibroblast growth factor after nocturnal hypoxic events in patients with obstructive sleep apnea syndrome |
| Q52728801 | Elevations in neutrophils with obstructive sleep apnea: The Multi-Ethnic Study of Atherosclerosis (MESA). |
| Q48137999 | Endothelial injury markers before and after nasal continuous positive airway pressure treatment for obstructive sleep apnoea hypopnoea syndrome. |
| Q47908376 | Endothelin-1 mediates intermittent hypoxia-induced inflammatory vascular remodeling through HIF-1 activation |
| Q47638104 | Evaluation of carotid arterial elasticity in patients with obstructive sleep apnea hypopnea syndrome by two-dimensional speckle tracking imaging. |
| Q35271821 | Excessive daytime sleepiness is associated with changes in salivary inflammatory genes transcripts |
| Q34360752 | Functional neuroanatomy and sleep-disordered breathing: implications for autonomic regulation. |
| Q47991048 | High prevalence of peripheral arterial disease in patients with obstructive sleep apnoea |
| Q37364445 | Hypertension and obstructive sleep apnoea syndrome: current perspectives |
| Q48516715 | Hypoxia-sensitive molecules may modulate the development of atherosclerosis in sleep apnoea syndrome |
| Q47939032 | Increased MCP-1 gene expression in monocytes of severe OSA patients and under intermittent hypoxia |
| Q48033119 | Increased plasma soluble tumor necrosis factor receptor-1 and myeloperoxidase activity in patients with obstructive sleep apnea syndrome |
| Q37701773 | Inflammation accelerates atherosclerotic processes in obstructive sleep apnea syndrome (OSAS). |
| Q35995458 | Inflammation and sleep in healthy individuals. |
| Q33759821 | Inflammatory markers and obstructive sleep apnea in obese children: the NANOS study |
| Q48500087 | Inflammatory measures in children with obstructive sleep apnoea |
| Q34492524 | Interactions between obesity and obstructive sleep apnea: implications for treatment |
| Q40539216 | Interleukin-8 promotes non-rapid eye movement sleep in rabbits and rats |
| Q64252636 | Intermittent Hypoxia Up-Regulates , and mRNAs in Adipocytes via Down-regulation of miR-452 |
| Q37441135 | Intermittent hypoxia and hypercapnia induce pulmonary artery atherosclerosis and ventricular dysfunction in low density lipoprotein receptor deficient mice |
| Q44427644 | Lipid peroxides, superoxide dismutase and circulating IL-8 and GCP-2 in patients with severe obstructive sleep apnea: a pilot study |
| Q37351440 | Mammillary bodies and fornix fibers are injured in heart failure |
| Q45975698 | Melatonin ameliorates endothelial dysfunction, vascular inflammation, and systemic hypertension in rats with chronic intermittent hypoxia. |
| Q37511434 | Metabolic consequences of sleep-disordered breathing |
| Q34907105 | Molecular biomarkers of vascular dysfunction in obstructive sleep apnea |
| Q37146506 | Molecular signatures of obstructive sleep apnea in adults: a review and perspective. |
| Q44854653 | Motor cortex plasticity induced by theta burst stimulation is impaired in patients with obstructive sleep apnoea |
| Q48455651 | N-terminal pro-B-type naturetic peptide (NTBNP): so much promise and such a disappointment |
| Q38118901 | Neurotoxic saboteurs: straws that break the hippo's (hippocampus) back drive cognitive impairment and Alzheimer's Disease |
| Q48464374 | Nocturnal change of circulating intercellular adhesion molecule 1 levels in children with snoring |
| Q48399515 | Nocturnal hypoxic stress activates invasive ability of monocytes in patients with obstructive sleep apnoea syndrome |
| Q35761898 | Non-arteritic anterior ischaemic optic neuropathy is nearly systematically associated with obstructive sleep apnoea |
| Q88312361 | Obstructive Sleep Apnoea and Vascular Disease in Patients with Type 2 Diabetes |
| Q38227380 | Obstructive sleep apnea and atrial arrhythmogenesis |
| Q38204508 | Obstructive sleep apnea and atrial fibrillation: understanding the connection |
| Q36830894 | Obstructive sleep apnea and coronary artery disease: from pathophysiology to clinical implications |
| Q38241505 | Obstructive sleep apnea and hypertension: a critical review |
| Q35070672 | Obstructive sleep apnea and progression of coronary artery calcium: the multi-ethnic study of atherosclerosis study |
| Q90324170 | Obstructive sleep apnea negatively impacts objectively measured physical activity |
| Q36779835 | Obstructive sleep apnea syndrome: natural history, diagnosis, and emerging treatment options |
| Q36767636 | Obstructive sleep apnea, cardiovascular disease, and inflammation--is NF-kappaB the key? |
| Q37464853 | Obstructive sleep apnea, immuno-inflammation, and atherosclerosis |
| Q35410946 | Obstructive sleep apnea: an emerging risk factor for atherosclerosis. |
| Q48410298 | Obstructive sleep apnoea and periodontitis: a novel association? |
| Q36117866 | Obstructive sleep apnoea as a risk factor for atherosclerosis - implication for preventive and personalised treatment |
| Q27025575 | Pathogenic roles of the carotid body inflammation in sleep apnea |
| Q35088802 | Patients with obstructive sleep apnea exhibit impaired endothelial function after myocardial infarction |
| Q47942038 | Phenotypic and Functional Characterization of Blood γδ T Cells in Sleep Apnea |
| Q37077148 | Positive pressure therapy: a perspective on evidence-based outcomes and methods of application. |
| Q48433718 | Prevalence of sleep disordered breathing in paroxysmal and persistent atrial fibrillation patients with normal left ventricular function |
| Q47882764 | Pro-atherogenic cytokine profile of patients with suspected obstructive sleep apnea |
| Q46742258 | Protective effect of melatonin against hippocampal injury of rats with intermittent hypoxia |
| Q36473686 | Pulmonary C-fiber activation attenuates respiratory-related tongue movements |
| Q38034108 | Quintessential risk factors: their role in promoting cognitive dysfunction and Alzheimer's disease |
| Q33730115 | Recognition and treatment of sleep-disordered breathing: an important component of chronic disease management |
| Q34994077 | Reduced caudate nuclei volumes in patients with congenital central hypoventilation syndrome |
| Q45073201 | Review of and Updates on Hypertension in Obstructive Sleep Apnea |
| Q48103325 | Risk factors for, and prevalence of, sleep apnoea in cardiac rehabilitation facilities in Germany: The Reha-Sleep registry |
| Q30494316 | SLEEP DISORDERED BREATHING AND METABOLIC EFFECTS: EVIDENCE FROM ANIMAL MODELS |
| Q28393387 | Serum from obstructive sleep apnea patients induces inflammatory responses in coronary artery endothelial cells |
| Q37549324 | Serum of obstructive sleep apnea patients impairs human coronary endothelial cell migration |
| Q48251845 | Silent brain infarction and platelet activation in obstructive sleep apnea |
| Q37243305 | Sleep Apnea and Metabolic Dysfunction: Cause or Co-Relation? |
| Q36645393 | Sleep and the metabolic syndrome |
| Q48301382 | Sleep difficulties and obesity among preadolescents. |
| Q37403214 | Sleep-disordered breathing and atrial fibrillation |
| Q33863155 | Sleep-disordered breathing and obesity: pathophysiology, complications, and treatment |
| Q34246426 | Sleep-disordered breathing is a risk factor for delirium after cardiac surgery: a prospective cohort study |
| Q46884212 | Structural equation modeling of sleep apnea, inflammation, and metabolic dysfunction in children |
| Q35675624 | The Association between Obstructive Sleep Apnea and Metabolic Markers and Lipid Profiles |
| Q21284813 | The Relationship between Obstructive Sleep Apnea and Atrial Fibrillation: A Complex Interplay |
| Q47982656 | The impact of obstructive sleep apnea on high-sensitivity C-reactive protein in subjects with or without metabolic syndrome |
| Q36990311 | The inflammatory preatherosclerotic remodeling induced by intermittent hypoxia is attenuated by RANTES/CCL5 inhibition |
| Q37407812 | The price of obstructive sleep apnea-hypopnea: hypertension and other ill effects |
| Q98186313 | The relationship between inflammation and neurocognitive dysfunction in obstructive sleep apnea syndrome |
| Q38552168 | The role inflammatory response genes in obstructive sleep apnea syndrome: a review |
| Q36304282 | Therapy Insight: interactions between atrial fibrillation and obstructive sleep apnea |
| Q36752050 | Translational approaches to understanding metabolic dysfunction and cardiovascular consequences of obstructive sleep apnea |
| Q41181154 | Treatment and prevention of inflammatory responses and oxidative stress in patients with obstructive sleep apnea hypopnea syndrome using Chinese herbal medicines |
| Q52890007 | [Sleep-disordered breathing and atrial fibrillation]. |
Search more.